-+ 0.00%
-+ 0.00%
-+ 0.00%

MicroPort Endovastec Aorfix endograft wins China NMPA green-channel designation

PUBT·08/27/2026 15:11:50
Listen to the news
MicroPort Endovastec Aorfix endograft wins China NMPA green-channel designation
  • MicroPort Endovastec’s Aorfix AAA endograft won China NMPA Green Channel status for innovative devices on Aug. 27, 2026.
  • Designation accelerates regulatory review for the stent graft, developed by European unit Lombard Medical, targeting complex abdominal aortic aneurysms.
  • Endovastec said Aorfix is cleared in Europe, the US, and Japan, positioning it for faster entry into China’s EVAR market.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MicroPort Scientific Corporation published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.